OXYFUSE-133
Dead / Abandoned — Abandoned — failure to respond (as of 18 Apr 2025)
What this means for you
This application is over — abandoned 17 Apr 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98155706
- Mark type
- Stylized text
- Filed
- 29 Aug 2023
- Published for opposition
- 18 Jun 2024
- Abandoned
- 17 Apr 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for spine fusions
Owner
- MAX BioPharma, Inc., Los Angeles, CA, US
- MAX BioPharma, Inc., Los Angeles, CA, US
Prosecution history
- 18 Apr 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 18 Apr 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 16 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Jan 2025 — NON-FINAL ACTION E-MAILED
- 16 Jan 2025 — SU - NON-FINAL ACTION - WRITTEN
- 06 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Dec 2024 — USE AMENDMENT FILED
- 06 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
- 13 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jun 2024 — PUBLISHED FOR OPPOSITION
- 29 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Apr 2024 — ASSIGNED TO EXAMINER